Shay Capital LLC - PHARMACYTE BIOTECH INC ownership

PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Shay Capital LLC ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q3 2022$2,438,000
+10.8%
1,015,666
+3.4%
0.53%
+19.0%
Q2 2022$2,201,000
+1.3%
982,698
+4.0%
0.44%
+58.4%
Q1 2022$2,173,000
+31.2%
944,666
+42.6%
0.28%
+1.8%
Q4 2021$1,656,000
+3500.0%
662,337
+4434.7%
0.27%
+4466.7%
Q3 2021$46,00014,6060.01%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ayrton Capital LLC 92,087$193,3831.31%
SABBY MANAGEMENT, LLC 97,124$203,9600.15%
K2 PRINCIPAL FUND, L.P. 258,481$542,8100.11%
EQUITEC PROPRIETARY MARKETS, LLC 82,727$173,7270.04%
CSS LLC/IL 13,186$27,6910.00%
Aspire Private Capital, LLC 800$1,6800.00%
Schonfeld Strategic Advisors LLC 23,300$48,9300.00%
OSAIC HOLDINGS, INC. 1,971$4,1390.00%
DIMENSIONAL FUND ADVISORS LP 29,307$61,5450.00%
BANK OF AMERICA CORP /DE/ 116$2430.00%
View complete list of PHARMACYTE BIOTECH INC shareholders